Skip to main content
Equibles

Mirae Asset Global Investments Co., Ltd.

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1569395 SEOUL, M5
Back to KNSA Full portfolio

Position in KNSA

as of Jun 30, 2026 · filed Jul 22, 2026
Position Value
$382,548
-$310,089 QoQ
Shares Held
5,982
-58.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#163
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $20,006,890 across 33 Drug Manufacturers - Specialty & Generic names. KNSA ranks #7 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 108,368 $7,787,323
2 VTRS
Viatris Inc
 305,332 $4,848,671
3 UTHR
UNITED THERAPEUTICS Corp
 4,119 $2,231,797
4 NBIX
Neurocrine Biosciences Inc
 9,700 $1,634,837
5 ELAN
Elanco Animal Health Inc
 23,364 $574,988
6 ALKS
Alkermes plc.
 7,454 $390,552
7 KNSA
Kiniksa Pharmaceuticals International, plc
This page 		5,982 $382,548
8 TEVA
Teva Pharmaceutical Industries Ltd
 8,947 $303,124

All Filings in KNSA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $382,548 5,982
2026-03-31 $692,637 14,385
2025-12-31 $585,172 14,186
2025-09-30 $454,349 11,701
2025-06-30 $45,240 1,635
2025-03-31 $32,204 1,450
2024-12-31 $27,395 1,385
2024-09-30 $36,710 1,469
2024-06-30 $22,460 1,203